Company intelligence / Profile preview
SkinMedica
Carlsbad, California, United Statesskinmedica.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SkinMedica has a long commercial track record with multiple professional-grade skincare products on the market. Its flagship innovation was the introduction of growth factor-based serums such as TNS Recovery Complex and TNS Essential Serum. The company also markets VANIQA cream, an FDA-approved prescription product for reducing unwanted facial hair in women. Clinical results supporting these products focus on visible improvements to skin appearance—such as reduced wrinkles or pigmentation—rather than traditional pharmaceutical endpoints.
- Therapeutic areas
- DermatologyWomen's Health
- Modalities
- Small moleculeProteinBiologicDevice
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major external pharma partnerships reported post-acquisition; previously partnered with Histogen via acquisition of Regenica line.
Beyond the preview
Go deeper on SkinMedica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SkinMedica.